Align Technology reported $193.04M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
3M USD 1.56B 57M Sep/2026
Align Technology USD 193.04M 1.72M Sep/2026
Becton, Dickinson and Co. USD 1.11B 357M Sep/2026
Bruker USD 83.5M 13.9M Sep/2026
Cardinal Health USD 819M 5M Sep/2026
Charles River Laboratories USD 202.64M 82.75M Sep/2026
Cooper Companies USD 222M 253M Jun/2026
CVS Health USD 3.57B 3.16B Sep/2026
Danaher USD 1.25B 118M Sep/2026
Dentsply International USD 38M 46M Sep/2026
Dexcom USD 318.3M 63M Jun/2026
Henry Schein USD 193M 7M Sep/2026
Idexx Laboratories USD 402.35M 23.22M Sep/2026
Insulet USD 189.8M 60.1M Sep/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
McKesson USD 1.69B 266M Sep/2026
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Revvity USD 124.63M 1.51M Sep/2026
Solventum Corp USD 68M 113M Sep/2026
Stryker USD 1.79B 687M Jun/2026
Teleflex USD -105.77M 178.84M Sep/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Veeva Systems USD 275.02M 1.91M Jun/2026
Waters USD -86M 234M Jun/2026
Zimmer Biomet Holdings USD 341.5M 3.2M Sep/2026
Zoetis USD 1.03B 88M Sep/2026